| Financial Year |
March 31 2023 |
| Monetary Funds |
7,680,179,181.23 |
| Held-for-trading Financial Assets |
60,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
334,861,959.85 |
| Advances to Suppliers |
347,215,866.58 |
| Other Receivables |
227,466,666.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,814,622,283.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,992,059.23 |
| Total Current Assets |
12,493,738,017.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
573,482,532.61 |
| Investment Properties |
-- |
| Fixed Assetes |
7,928,348,085.39 |
| Under-construction Projects |
123,568,828.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
954,600,330.17 |
| R&D expenses |
-- |
| Goodwill |
81,013,576.72 |
| Long-Term Deferred and Prepaid Expenses |
3,772,599.27 |
| Deferred Income Tax Assets |
33,584,171.19 |
| Other Non-Current Assets |
157,171,017.41 |
| Sub-Total of Non-Current Assets |
9,873,903,321.85 |
| Total Assets |
22,367,641,339.35 |
| Short-Term Loans |
1,601,090,390.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,557,364,717.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
92,823,669.52 |
| Taxes Payable |
339,439,631.13 |
| Interest Payable |
911,865.76 |
| Dividend Payable |
84,836,391.48 |
| Other payables |
2,832,916,959.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,724,871.86 |
| Other Current Liabilities |
158,348,555.73 |
| Sub-Total of Current Liabilities |
7,815,792,320.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,246,883.83 |
| Other Non-Current Liabilities |
150,000,000.00 |
| Sub-Total of Non-Current Liabilities |
195,972,896.14 |
| Total Liabilities |
8,011,765,216.82 |
| Paid-In Capital(Or Share Stock) |
2,818,539,341.00 |
| Capital Surplus |
4,374,276,133.64 |
| Surplus Reserve |
2,323,466,095.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,039,051,120.57 |
| Minority Stockholder's Interest |
865,543,431.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,490,332,690.95 |
| Owner's Equity（Stockholder's Equity） |
14,355,876,122.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,367,641,339.35 |
